Información de la revista
Vol. 58. Núm. 6.
Páginas 519-522 (junio 2003)
Vol. 58. Núm. 6.
Páginas 519-522 (junio 2003)
Acceso a texto completo
Drogas en el embarazo y morbilidad neonatal
Visitas
19992
J. Echeverria Lecuona*
Unidad de Neonatología. Servicio de Pediatría. Hospital Donostia. San Sebastián. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
BibliografÍa
[1.]
J.J. Kelly, P.G. Davis, P.N. Henschke.
The drug epidemic: Effects on newborn infants and health resource consumption at a tertiary perinatal centre.
J Paediatr Child Health, 36 (2000), pp. 262-264
[2.]
V. Moe, K. Slinning.
Prenatal drug exposure and the conceptualization of long-term effects.
Scand J Psychol, 43 (2002), pp. 41-47
[3.]
L.M. Smith, L. Chang, M.L. Yonekura, K. Gilbride, J. Kuo, R.E. Poland, et al.
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero.
Pediatrics, 107 (2001), pp. 227-231
[4.]
F.D. Eyler, M. Behnke, C.W. Garvan, N.S. Woods, K. Wobie, M. Colon.
Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure.
Neurotoxicology Teratology, 23 (2001), pp. 399-411
[5.]
E.B. Leckman, L.C. Mayes, H.S. Hodgins.
Perceptions and attitudes toward prenatal cocaine exposure in young children.
Child Psychiatry Human Development, 31 (2001), pp. 312-313
[6.]
V.H. Accornero, C.E. Morrow, E.S. Bandstra, A.L. Johnson, J.C. Anthony.
Behavioral outcome of preschoolers exposed prenatally to cocaine: Role of maternal behavioral health.
J Pediatr Psychol, 27 (2002), pp. 259-269
[7.]
E.S. Mitchell, R.W. Keller Jr., A. Snyder-Keller.
Immediate-early gene expression in concurrent prenatal ethanol- and/or cocaine-exposed rat pups: Intrauterine differences in cocaine levels and Fos expression.
Brain Research. Developmental Brain Research, 133 (2002), pp. 141-149
[8.]
A.L. Lux, A.J. Henderson, S.J. Pocock.
The ALSPAC study Team. Wheeze associated with prenatal tobacco smoke exposure: A prospective, longitudinal study.
Arch Dis Child, 83 (2000), pp. 307-312
[9.]
J. Cano Fernández, C. Zabaleta Camino, E. De la Torre Montes de Neira, G.A. Yep Chulen, J.M. Melendi Crespo, M. Sánchez Bayle.
Tabaquismo pasivo prenatal y postnatal y bronquiolitis.
An Pediatr, 58 (2003), pp. 115-120
[10.]
A.M. Butz, M. Pulsifer, N. Marano, H. Belcher, M.K. Lears, R. Royall.
Effectiveness of a home intervention for perceived child behavioral problems and parenting stress in children with in utero drug exposure.
Arch Pediatr Adol Med, 155 (2001), pp. 1029-1037
[11.]
P.V. Thadani.
The intersection of stress, drug abuse and development.
Psychoneuroendocrinology, 27 (2002), pp. 221-230
[12.]
L.P. Finnegan, J.F. Connaughton, R.E. Kron, J.P. Emich.
Neonatal abstinence syndrome: Assessment and management.
Addict Dis, 2 (1975), pp. 141-158
[14.]
R. White-Traut, T. Studer, P. Meleedy-Rey, P. Murray, S. Labovsky, J. Kahn.
Pulse rate and behavioral state correlates after auditory, tactile, visual, and vestibular intervention in drug-exposed neonates.
J Perinatol, 22 (2002), pp. 291-299
[15.]
C.M. O'Brien, H.E. Jeffery.
Sleep deprivation, disorganization and fragmentation during opiate withdrawal in newborns.
J Paediatr Child Health, 38 (2002), pp. 66-71
[16.]
C. Floch-Tudal, A.M. Simonpoli, S. Montamat, M.P. Couettoux, C. Crenn-Hebert, C. Lejeune.
Neonatal withdrawal syndrome in twins born to a mother on methadone substitution.
Ann Med Intern, 151(Suppl B) (2000), pp. 30-33
[17.]
K.C. D'Apolito, T.I. McRorie.
Pharmacologic management of neonatal abstinence syndrome.
J Perinat Neonat Nursing, 9 (1996), pp. 70-80
[18.]
J.G. Theis, P. Selby, Y. Ikizler, G. Koren.
Current management of the neonatal abstinence syndrome: A critical analysis of the evidence.
Biol Neonate, 71 (1997), pp. 345-356
[19.]
M.G. Coyle, A. Ferguson, L. Lagasse, W. Oh, B. Lester.
Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants.
J Pediatr, 140 (2002), pp. 561-564
[20.]
M. Tenenbein, O.G. Casiro, M.M. Seshia, V.D. Debooy.
Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child.
Fetal Neonatol, 74 (1996), pp. 204-207
[21.]
M. Ziegler, F. Poustka, V. Von Loewenich, E. Englert.
Postpartum risk factors in the development of children born to opiateaddicted mothers; comparison between mothers with and without methadone substitution.
Nervenarzt, 71 (2000), pp. 730-736
[22.]
E. Gomart.
Methadone: Six effects in search of a substance.
Soc Stud Science, 32 (2002), pp. 93-135
[23.]
J.L. Ballard.
Treatment of neonatal abstinence syndrome with breast milk containing methadone.
J Perinat & Neonat Nurs, 15 (2002), pp. 76-85
Copyright © 2003. Asociación Española de Pediatría